Sfoglia per AUTORE
LABOPIN M
Collezione AOU Città della Salute di Torino

  

Items : 29

Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT. in Journal of hematology & oncology / J Hematol Oncol. 2023 Sep 29;16(1):106. doi: 10.1186/s13045-023-01501-w.

2023
AOU Città della Salute di Torino

Nagler A; Labopin M; Blaise D; Raiola AM; Corral LL; Bramanti S; Sica S; Kwon M; Koc Y; Pavlu J; Kulagin A; Busca A; Rodríguez AB; Reményi P; Schmid C; Brissot E; Sanz J; Bazarbachi A; Giebel S; Ciceri F; Mohty M;

Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT. in Journal of hematology & oncology / J Hematol Oncol. 2023 May 29;16(1):58. doi: 10.1186/s13045-023-01450-4.

2023
AOU Città della Salute di Torino

Nagler A; Labopin M; Blaise D; Raiola AM; Corral LL; Bramanti S; Sica S; Kwon M; Koc Y; Pavlu J; Kulagin A; Busca A; Rodríguez AB; Reményi P; Schmid C; Brissot E; Sanz J; Bazarbachi A; Giebel S; Ciceri F; Mohty M;

Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis. in HemaSphere / Hemasphere. 2023 Feb 21;7(3):e846. doi: 10.1097/HS9.0000000000000846. eCollection 2023 Mar.

2023
AOU Città della Salute di Torino

Hermans SJF; Versluis J; Labopin M; Giebel S; van Norden Y; Moiseev I; Blaise D; Díez Martín JL; Meijer E; Rovira M; Choi G; Raiola AM; Koc Y; Reményi P; Vydra J; Kröger N; Sica S; Martino M; van Gorkom G; Chevallier P; Busca A; Herrera Arroyo C; Brissot E; Peric Z; Nagler A; Shouval R; Ciceri F; Cornelissen JJ; Mohty M; et alii...

Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party of the EBMT. in HemaSphere / Hemasphere. 2023 Jun 27;7(7):e920. doi: 10.1097/HS9.0000000000000920. eCollection 2023 Jul.

2023
AOU Città della Salute di Torino

Kharfan-Dabaja MA; Labopin M; Ayala E; Bazarbachi A; Blaise D; Vydra J; Bramanti S; Itälä-Remes M; Schmid C; Busca A; Forcade E; Rabitsch W; Zecca M; Kröger N; Bulabois CE; Grillo G; Rambaldi A; Fanin R; Zallio F; Di Renzo N; Koc Y; Novis Y; McDonald A; Herrera Arroyo C; Sanz J; Nagler A; Ciceri F; Mohty M;

Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Sep;57(9):1421-1427. doi: 10.1038/s41409-022-01674-x. Epub 2022 Jun 25.

2022
AOU Città della Salute di Torino

Neubauer A; Avenoso D; Yakoub-Agha I; Arroyo H; Bay JO; Olivieri A; Vrhovac R; Charbonnier A; Bruno B; Bug G; Stölzel F; Martino M; Chalandon Y; Socié G; Castagna L; Pavlu J; Raiola AM; Blaise D; Labopin M; Galimard JE; Devillier R; Nguyen S; Forcade E; Brissot E; Savani B; Nagler A; Mohty M;

Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Nov;28(11):773.e1-773.e8. doi: 10.1016/j.jtct.2022.08.018. Epub 2022 Aug

2022
AOU Città della Salute di Torino

Brissot E; Giebel S; Spyridonidis A; Sanz J; Savani BN; Canaani J; Bornhäuser M; Jindra P; Bulabois CE; Chevallier P; Vydra J; Forcade E; Bruno B; Fanin R; Blaise D; Fraccaroli A; Ciceri F; Dholaria B; Nagler A; Labopin M; Bazarbachi A; Esteve J; Mohty M;

Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Nov;57(11):1657-1663. doi: 10.1038/s41409-022-01781-9. Epub 2022 Aug 17

2022
AOU Città della Salute di Torino

Simand C; Carella AM; Kulagin A; Passweg J; Rösler W; Forcade E; Chevallier P; Koc Y; Jindra P; Busca A; Stölzel F; Bulabois CE; Diez-Martin JL; Fanin R; Vydra J; Sica S; Raiola AM; Blaise D; Ciceri F; Tischer J; Labopin M; Baron F; Bazarbachi A; Pioltelli P; Nagler A; Mohty M;

Correction: Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Nov;57(11):1747. doi: 10.1038/s41409-022-01856-7.

2022
AOU Città della Salute di Torino

Baron F; Labopin M; Tischer J; Ciceri F; Raiola AM; Blaise D; Sica S; Vydra J; Fanin R; Diez-Martin JL; Bulabois CE; Stölzel F; Busca A; Jindra P; Koc Y; Chevallier P; Forcade E; Rösler W; Passweg J; Kulagin A; Carella AM; Simand C; Bazarbachi A; Pioltelli P; Nagler A; Mohty M;

The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Mar;57(3):384-390. doi: 10.1038/s41409-021-01493-6. Epub 2022 Jan 13.

2022
AOU Città della Salute di Torino

Shimoni A; Labopin M; Angelucci E; Blaise D; Ciceri F; Koc Y; Gülbas Z; Diez-Martin JL; Bruno B; Castagna L; Martino M; Rovira M; Mohty M; Nagler A;

Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP). in Bone marrow transplantation / Bone Marrow Transplant. 2022 Dec;57(12):1803-1809. doi: 10.1038/s41409-022-01830-3. Epub 2022 Sep 22

2022
AOU Città della Salute di Torino

Bazarbachi A; Giebel S; Savani B; Anagnostopoulos A; Ozdogu H; Sanz J; Busca A; Zuckerman T; Mielke S; Kröger N; Hilgendorf I; Rambaldi A; Berceanu A; Potter V; Yakoub-Agha I; Salmenniemi U; Sakellari I; Gavriilaki E; Labopin M; Spyridonidis A; Nagler A; Mohty M;

Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients??55?years of age. in American journal of hematology / Am J Hematol. 2022 Aug;97(8):1065-1074. doi: 10.1002/ajh.26627. Epub 2022 Jun 24.

2022
AOU Città della Salute di Torino

Koc Y; Diez-Martin JL; Busca A; Stölzel F; Vydra J; Fanin R; Sica S; Blaise D; Ciceri F; Raiola AM; Tischer J; Labopin M; Baron F; Nagler A; Mohty M;

Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Apr;57(4):562-571. doi: 10.1038/s41409-022-01577-x. Epub 2022 Jan 25.

2022
AOU Città della Salute di Torino

Forcade E; Choi G; Corral LL; Tischer J; Martin H; Pavlu J; Arat M; Socié G; Nguyen S; Bulabois CE; Grillo G; Araujo MC; Martino M; Moiseev I; Rovira M; Bruno B; Castagna L; Sica S; Diez-Martin JL; Vitek A; Gülbas Z; Koc Y; Ruggeri A; Raiola AM; Blaise D; Labopin M; Galimard JE; Battipaglia G; McDonald A; et alii...

Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Sep;56(9):2194-2202. doi: 10.1038/s41409-021-01317-7. Epub 2021 Apr 30.

2021
AOU Città della Salute di Torino

Brissot E; Ruggeri A; Sanz J; Diez-Martin JL; Blaise D; Benedetti F; Zuckerman T; Tischer J; Schmid C; Potter V; Kuball J; Caballero D; Brecht A; Angelucci E; Valerius T; Niittyvuopio R; Labussière-Wallet H; Gedde-Dahl T; Bornhäuser M; Bruno B; Finke J; Bazarbachi A; Ciceri F; Labopin M; Kharfan-Dabaja MA; Savani BN; Giebel S; Nagler A; Mohty M; et alii...

The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Jan;56(1):20-29. doi: 10.1038/s41409-020-0974-6. Epub 2020 Jun 19.

2021
AOU Città della Salute di Torino

Savani BN; Finke J; Franke GN; Saccardi R; Ruggeri M; Mielke S; Socié G; La Nasa G; Pioltelli P; Rambaldi A; Bruno B; Labopin M; Dholaria B; Nagler A; Ruggeri A; Mohty M;

Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Aug;56(8):1842-1849. doi: 10.1038/s41409-021-01248-3. Epub 2021 Mar 5.

2021
AOU Città della Salute di Torino

Martino M; Arat M; Bruno B; Castagna L; Gülbas Z; Diez-Martin JL; Koc Y; Chiusolo P; Ciceri F; Blaise D; Angelucci E; Labopin M; Ruggeri A; Nagler A; Mohty M;

Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2020 Oct;26(10):1915-1922. doi: 10.1016/j.bbmt.2020.06.026. Epub 2020

2020
AOU Città della Salute di Torino

Ruggeri A; Labopin M; Battipaglia G; Chiusolo P; Tischer J; Diez-Martin JL; Bruno B; Castagna L; Moiseev IS; Vitek A; Rovira M; Ciceri F; Bacigalupo A; Nagler A; Mohty M; Ruggeri A; Labopin M; Battipaglia G; Chiusolo P; Tischer J; Diez-Martin JL; Bruno B; Castagna L; Moiseev IS; Vitek A; Rovira M; Ciceri F; Bacigalupo A; Nagler A; et alii...

Impact of total body irradiation- vs chemotherapy-based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia. in American journal of hematology / Am J Hematol. 2020 Oct;95(10):1200-1208. doi: 10.1002/ajh.25934. Epub 2020 Aug 6.

2020
AOU Città della Salute di Torino

Dholaria B; Labopin M; Angelucci E; Ciceri F; Diez-Martin JL; Bruno B; Sica S; Koc Y; Gülbas Z; Schmid C; Blaise D; Carella AM; Visani G; Savani BN; Nagler A; Mohty M;

Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2020 May;20(5):296-304. doi: 10.1016/j.clml.2020.01.007. Epub 2020 Jan 2

2020
AOU Città della Salute di Torino

La Nasa G; Iori AP; Bruno B; Castagna L; Carella AM; Bonifazi F; Santarone S; Bazarbachi A; Angelucci E; Al-Chami F; Labopin M; El-Cheikh J; Savani B; Nagler A; Mohty M;

Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over. in Cancer / Cancer. 2019 May 1;125(9):1499-1506. doi: 10.1002/cncr.31941. Epub 2019 Jan 8.

2019
AOU Città della Salute di Torino

Santoro N; Labopin M; Ciceri F; Van Lint MT; Nasso D; Blaise D; Arcese W; Tischer J; Bruno B; Ehninger G; Koc Y; Santarone S; Huang XJ; Savani BN; Mohty M; Ruggeri A; Nagler A;

Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT. in Journal of hematology & oncology / J Hematol Oncol. 2019 Jul 4;12(1):68. doi: 10.1186/s13045-019-0751-4.

2019
AOU Città della Salute di Torino

Piemontese S; Boumendil A; Labopin M; Schmid C; Ciceri F; Arcese W; Koc Y; Gulbas Z; Tischer J; Bruno B; Wu D; Blaise D; Beelen D; Irrera G; Ruggeri A; Houhou M; Mohty M; Nagler A;

Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide. in Leukemia / Leukemia. 2019 Jan;33(1):230-239. doi: 10.1038/s41375-018-0170-5. Epub 2018 Jun 15.

2019
AOU Città della Salute di Torino

Ciceri F; Afanasyev B; Pioltelli P; Blaise D; Bruno B; Gülbas Z; Tischer J; Koc Y; Van Lint MT; Lorentino F; Labopin M; Shimoni A; Mohty M; Nagler A;

Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia. in American journal of hematology / Am J Hematol. 2018 Oct;93(10):1211-1219. doi: 10.1002/ajh.25225. Epub 2018 Aug 15.

2018
AOU Città della Salute di Torino

Saraceni F; Beohou E; Labopin M; Arcese W; Bonifazi F; Stepensky P; Aljurf M; Bruno B; Pioltelli P; Passweg J; Sociè G; Santarone S; Yakoub-Agha I; Lanza F; Savani BN; Mohty M; Nagler A; Saraceni F; Beohou E; Labopin M; Arcese W; Bonifazi F; Stepensky P; Aljurf M; Bruno B; Pioltelli P; Passweg J; Sociè G; Santarone S; et alii...

T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. in American journal of hematology / Am J Hematol. 2018 Jun;93(6):736-744. doi: 10.1002/ajh.25082. Epub 2018 Mar 23.

2018
AOU Città della Salute di Torino

Canaani J; Labopin M; Huang XJ; Arcese W; Ciceri F; Blaise D; Irrera G; Corral LL; Bruno B; Santarone S; Van Lint MT; Vitek A; Esteve J; Mohty M; Nagler A;

Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation. in American journal of hematology / Am J Hematol. 2018 Feb;93(2):246-253. doi: 10.1002/ajh.24963. Epub 2017 Dec 6.

2018
AOU Città della Salute di Torino

Mohty M; Bruno B; Van Lint MT; Gülbas Z; Blaise D; Tischer J; Koc Y; Arcese W; Ciceri F; Huang XJ; Savani BN; Labopin M; Canaani J; Nagler A;

Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine. in Journal of hematology & oncology / J Hematol Oncol. 2018 Aug 30;11(1):110. doi: 10.1186/s13045-018-0655-8.

2018
AOU Città della Salute di Torino

Giannotti F; Labopin M; Shouval R; Sanz J; Arcese W; Angelucci E; Sierra J; Santasusana JR; Santarone S; Benedetto B; Rambaldi A; Saccardi R; Blaise D; Carella MA; Rocha V; Baron F; Mohty M; Ruggeri A; Nagler A; Giannotti F; Labopin M; Shouval R; Sanz J; Arcese W; Angelucci E; Sierra J; Santasusana JR; Santarone S; Benedetto B; et alii...

Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. in Haematologica / Haematologica. 2018 Aug;103(8):1317-1328. doi: 10.3324/haematol.2018.189258. Epub 2018 May 10.

2018
AOU Città della Salute di Torino

Huynh A; Bruno B; Van Lint MT; Bourhis JH; Sociè G; Arcese W; Blaise D; Ciceri F; Ghavamzadeh A; Battipaglia G; Ruggeri A; Labopin M; Salvatore D; Santarone S; Deconinck E; Mohty M; Nagler A; Salvatore D; Labopin M; Ruggeri A; Battipaglia G; Ghavamzadeh A; Ciceri F; Blaise D; Arcese W; Sociè G; Bourhis JH; Van Lint MT; Bruno B; et alii...

Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide. in Cancer / Cancer. 2018 Apr 1;124(7):1428-1437. doi: 10.1002/cncr.31228. Epub 2018 Jan 23.

2018
AOU Città della Salute di Torino

Ruggeri A; Labopin M; Bacigalupo A; Gülbas Z; Koc Y; Blaise D; Bruno B; Irrera G; Tischer J; Diez-Martin JL; Castagna L; Ciceri F; Mohty M; Nagler A;

Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT. in Haematologica / Haematologica. 2017 Jun;102(6):1066-1074. doi: 10.3324/haematol.2016.160804. Epub 2017 Mar 2.

2017
AOU Città della Salute di Torino

Canaani J; Savani BN; Labopin M; Huang XJ; Ciceri F; Arcese W; Tischer J; Koc Y; Bruno B; Gülbas Z; Blaise D; Maertens J; Ehninger G; Mohty M; Nagler A;

Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant. in Haematologica / Haematologica. 2017 Feb;102(2):401-410. doi: 10.3324/haematol.2016.151779. Epub 2016 Oct 6.

2017
AOU Città della Salute di Torino

Koc Y; Diez-Martin JL; Bruno B; Malard F; Ghavamzadeh A; Messina G; Blaise D; Gülbas Z; Santarone S; Arcese W; Lorentino F; Bacigalupo A; Labopin M; Sun Y; Ruggeri A; Ciceri F; Mohty M; Nagler A;